At Veranex, Lauren supports product launches by conducting conjoint analyses, pricing assessments, and quantitative market research involving medical devices, diagnostic tools, and pharmaceuticals. She designs online surveys to provide strategic insights regarding clinical positioning, product development, and market sizing, and also develops health economic models and product forecasts for a variety of conditions, including oncology.
Prior to joining Veranex, she conducted unmet need analyses for two pharmaceutical consulting firms: Equinox Group and MORPACE Pharma, Inc. Lauren worked as a consultant and analyst on a range of indications including cardiovascular disease, central nervous system disorders, gastrointestinal disease, metabolic disorders, infectious disease, and ophthalmologic conditions. For her pharmaceutical clients, Lauren created competitive assessments of their developmental drugs, evaluated licensing opportunities, and developed complex, dynamic models to estimate drugs’ expected sales and market shares. Before consulting for pharmaceutical companies, she worked on cost/benefit analyses as a research analyst for Industrial Economics, an environmental economics consulting firm.
Lauren received her B.A. in economics and French from Amherst College and an MBA from the Johnson Graduate School of Management at Cornell University and her undergraduate degree in economics and French from Amherst College. She is a member of Phi Beta Kappa and Beta Gamma Sigma.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)